Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product (Standard Formula, Disease-specific Formula), By Flow Type, By Stage, By Indication, By End-use, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product (Standard Formula, Disease-specific Formula), By Flow Type, By Stage, By Indication, By End-use, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

Enteral Feeding Formulas Market Growth & Trends

The global enteral feeding formulas market size is expected to reach USD 10.5 billion by 2030, expanding at 5.5% CAGR from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of targeted diseases and advancements in drug development are expected to drive the demand for disease-specific formulas. Clinical nutrition is increasingly used for the personalized treatment of diseases, such as cancer and cystic fibrosis. These conditions require special nutrition to avoid any kind of drug interaction.

For instance, in the case of cystic fibrosis, special digestive enzyme capsules are administered. The nature of these digestive enzymes can vary in individuals. Appropriate nutrition is critical for preterm infants, and early nutrition provision could influence better clinical outcomes & growth of the child, including neurodevelopment, decreased risk of Retinopathy of Prematurity (ROP), or prevention of Bronchopulmonary Dysplasia (BPD).

The commitment of NPOs and NGOs to preventing and caring for preterm birth, such as the ‘Every Woman Every Child’ movement of the UN, to advance the global strategy on women’s and children's health, is expected to boost the demand for neonatal & preterm enteral feeding formulas. Growing initiatives to spread awareness regarding the importance of nutrients among the patient population are expected to improve the current market scenario.

According to an article titled ASPEN Strives to Address Critical Gaps in Diagnoses, Care, and Treatment through Annual Malnutrition Awareness Week, published by ASPEN, around 10 hospitalized patients go undiagnosed every 60 seconds. Hence, this organization established Malnutrition Awareness Week in 2011 to spread awareness regarding malnutrition in hospitalized patients and educate healthcare professionals on the importance of nutrients among patients.

In case of medical necessity, Medicaid must cover enteral nutrition. However, there are no such regulations/mandates on private insurance companies. Moreover, as per the results of a survey conducted by NCBI, there is a huge lack of reimbursement for patients on Home Enteral Nutrition (HEN) and inadequate awareness among stakeholders regarding market opportunities, especially in lower-income countries.

Enteral Feeding Formulas Market Report Highlights

• Based on product, the standard formula segment led the market, accounting for 56.8 % of the market share in 2023. The availability of a wide variety of standard formulas, coupled with increased demand for low-cost nutrient formulations, are among the factors driving the market growth
• The disease-specific formula segment is expected to witness a lucrative CAGR of 6.0% over the forecast period. The high prevalence of chronic diseases, such as cancer, diabetes, and liver failure, is propelling the demand for disease-specific formulas
• Based on flow type, the intermittent flow segment dominated the market with a share of 89.2% in 2023. This can be attributed to the fact that intermittent feeding has shown better tolerance in patients as compared to bolus feeding
• Based on stage, the adult segment, accounted for 90.4% of the overall market share in 2023, and is anticipated to be the fastest-growing segment over the forecast period
• The other indications segment accounted for the largest market share of 37.3% in 2023; the segment was followed by cancer. The dominant share can be attributed to the increasing incidences of malnutrition and other conditions associated with critically ill patients whose immune system is impaired
• In 2023, home care was the largest end-use segment with a share of 60.1% and is expected to witness the fastest growth over the forecast period

Please note The report will be delivered in 2-3 business days upon order notification.